SYSTEMATIX GROUP Says Tariffs on pharma will be harmful for India and US both - ETNOW Tariffs will be unproductive for both countries Pharma sector is in transition phase US Business will be difficult for big players Going ahead 8 to 11% growth In India business expected FY27 will be difficult for Pharma Companies